Cell line to be used to support research and development of biotherapeutics across therapeutic areas Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company” or “the Group”), a global leader in the application of gene editing and gene modulation for cell line engineering, today announced that it will license its gene-edited Glutamine Synthetase […]
— Contract Focused on Making DNA Data Storage Commercially Accessible — SAN FRANCISCO– Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has been selected as a subcontractor to Georgia Tech Research Institute (GTRI) to undertake the DNA […]
Complete solution for physical characterization backed by established application expertise Norcross, GA – Particle Testing Authority, Micromeritics’ ISO17025 accredited contract testing laboratory today announced a comprehensive physical characterization service for the additive manufacturing (AM) industry that provides fast and efficient access to the techniques routinely used to optimize process performance and the attributes of finished […]
Fluidigm microfluidics technology to fuel growth in genomics services SOUTH SAN FRANCISCO, Calif. — MOgene, a leading provider of genomic and bioinformatic services in St. Louis, today announced it has selected Fluidigm’s (NASDAQ:FLDM) Advanta™ assays and microfluidics-based Juno™ system to expand its next-generation sequencing (NGS) services portfolio. Using Fluidigm’s recently released Advanta RNA-Seq NGS Library […]
• Milestone instrument placed with Cenata GmbH in Germany • More than 30 diagnostic assays, including eight FDA approved tests available for the system • Launch of new PowerFecal Pro Kit automating microbiome sample preparation Hilden, Germany, and Germantown, Maryland, January 9, 2020 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the 2,500th […]
CytomX implements off-the-shelf Genedata workflow platform to accelerate development and manufacture of proprietary biotherapeutic modalities for cancer treatment SAN FRANCISCO (PRWEB) — Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that CytomX Therapeutics, a clinical-stage oncology-focused biopharmaceutical company, has licensed Genedata Bioprocess® to act as an integrated workflow backbone for its […]
A new generation of Bionano-based assays to be brought to the clinic by GeneDx SAN DIEGO — Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets the Saphyr® System, a genome imaging platform for ultra-sensitive and ultra-specific genome-wide structural variation detection, today announced the adoption of Saphyr by GeneDx, Inc., […]
Saphyr helps provide a better understanding of ALS, Alzheimer’s disease and Parkinson’s disease SAN DIEGO — Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that Mayo Clinic has adopted the Saphyr system. A team led by Dr. Mark Ebbert brought the Saphyr system in-house after determining that Bionano’s technology can provide a deeper understanding of the […]
SOUTH SAN FRANCISCO — Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced today that The University of Michigan Protein Assembly Lab, a hub for collaborative and innovative research at the intersection of synthetic biology, protein engineering and personalized medicine, has chosen the Hyperion™ Imaging […]
Today, a new, large-scale population genomics project was announced by the Department of Health in Abu Dhabi, UAE. The programme aims to improve the understanding of the genomics of individuals in the region as part of a personalised medicine initiative. The project is also exploring ways to deliver participants their own genomes as part […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
